Dermadream operates in the skincare and pharmaceutical industries, focusing on aesthetic product distribution and skincare devices. The company is the exclusive distributor of AestheFill, a dermal filler, in Brazil and actively participates in industry events, such as the Congress of the Brazilian Society of Botulinum Toxin and Facial Aesthetics. In addition to distribution, Dermadream markets its own line of skincare devices under the My Derma Dream brand. This includes the FDA-cleared MicroSculpt microcurrent device, designed to enhance circulation and muscle tone, as well as red light therapy devices aimed at anti-aging. The company targets Brazilian aesthetic professionals and consumers, promoting its products with a 90-day money-back guarantee. Dermadream's dual focus on B2B and B2C markets positions it uniquely within the industry.
我们正在追踪 Dermadream 的市场扩张
Dermadream 的国际扩张与竞争对手的对比情况
Dermadream你条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 Dermadream你 | 0 | 0 | — | 0 | 0 |
当前没有招聘
注册以跟踪该公司，并在发生变化时第一时间获得提醒。
没有进行中的营销活动
注册以跟踪该公司，并在发生变化时第一时间获得提醒。
Hugel与巴西Derma Dream合作，瞄准拉丁美洲肉毒素市场。在里约热内卢和圣保罗举行'Letybo'预发布活动。
Hugel为60名巴西皮肤科医生举办了为期3天的研讨会，以加深对Letybo品牌的理解，包括诊所参观、工厂参观和交流会议。
PharmaResearch与DermaDream签署Rejuran在巴西的独家供应协议，标志着进军拉丁美洲美容市场的战略性举措。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Dermadream 的业务、市场和增长信号的快速解答。
